Hutchison China MediTech Limited (HCM) Stock Rating Reaffirmed by Beaufort Securities

Hutchison China MediTech Limited (LON:HCM)‘s stock had its “buy” rating reiterated by analysts at Beaufort Securities in a research note issued to investors on Wednesday.

Separately, Panmure Gordon reissued a “buy” rating and set a GBX 2,630 ($32.87) price target on shares of Hutchison China MediTech Limited in a report on Thursday, January 26th.

Hutchison China MediTech Limited (LON:HCM) opened at 2150.00 on Wednesday. Hutchison China MediTech Limited has a 12-month low of GBX 1,612.50 and a 12-month high of GBX 2,470.00. The stock’s market capitalization is GBX 1.30 billion. The firm has a 50-day moving average of GBX 2,226.08 and a 200-day moving average of GBX 1,991.71.

This news story was originally published by sleekmoney and is the property of of sleekmoney. If you are viewing this news story on another website, it was illegally copied and reposted in violation of United States and international copyright law. The legal version of this news story can be viewed at http://sleekmoney.com/hutchison-china-meditech-limited-hcm-stock-rating-reaffirmed-by-beaufort-securities/1661709.html.

In other news, insider Michael Howell sold 3,000 shares of the firm’s stock in a transaction on Monday, November 21st. The stock was sold at an average price of GBX 1,890 ($23.62), for a total transaction of £56,700 ($70,857.29).

About Hutchison China MediTech Limited

Hutchison China MediTech Limited (Chi-Med) is a China-based, globally-focused healthcare group. The Company researches, develops, manufactures and sells pharmaceuticals and health-related consumer products. Its Innovation Platform focuses on discovering and developing therapeutics in oncology and autoimmune diseases for the global market.

This story was originally published by sleekmoney (http://sleekmoney.com) and is the sole property of sleekmoney. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at http://sleekmoney.com/hutchison-china-meditech-limited-hcm-stock-rating-reaffirmed-by-beaufort-securities/1661709.html

Receive News & Ratings for Hutchison China MediTech Limited Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hutchison China MediTech Limited and related companies with MarketBeat.com's FREE daily email newsletter.

 

Leave a Reply

Your email address will not be published. Required fields are marked *